Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: J Surg Res. 2014 Mar 20;190(1):55–63. doi: 10.1016/j.jss.2014.03.036

Fig. 1. Oridonin suppresses HSC proliferation.

Fig. 1

Chemical structure of oridonin (A). LX-2 cells (B), HSC-T6 cells (C) and C3A hepatocytes (D) were treated with a series of concentrations of oridonin for 48 hours, and cell viability was determined using Alamar Blue assay. (E) LX-2 cells were treated with 7.5 μmol/L of oridonin for 24, 48, and 72 hours; cell viability was measured by Alamar Blue assay. P-values shown compared to vehicle (0.1% DMSO, 0 μmol/L). The results are representative of at least three independent experiments.